Clinicopathological characteristics and outcome of adult patients with hematuria and/or proteinuria found during routine examination

Nephron - Clinical Practice

Volumn 103, Issue 4, 2006, Pages

  Shen, Peicheng ^a,b   Ding, Xiaoqiang ^a   Ten, Jie ^a   Ji, Jun ^a   Zou, Jianzhou ^a   Fang, Yi ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Glomerular disease; Hematuria; Hypertension; Proteinuria; Proteinuria hematuria, routine examination; Renal insufficiency; Urinalysis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PATHOLOGY; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; HEMATURIA; HUMANS; HYPERTENSION, RENAL; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PROGNOSIS; PROTEINURIA; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 33746324512     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092912     Document Type: Article

References (32)

1. Yamagata K, Takahashi H, Tomida C, Yamagata Y, Koyama A: Prognosis of asymptomatic hematuria and/or proteinuria in men. Nephron 2002;91:34-42.
2. House A, Cattran C: Evaluation of asymptomatic hematuria and proteinuria in adult primary care. CMAJ 2002;166:348-359.
3. Simon P, Ramee MP, Autuly V, Laruelle E, Charasse C, Cam G: Epidemiology of primary glomerular diseases in a French region: variations according to period and age. Kidney Int 1994;46:1192-1198.
4. Shu KH, Ho WL, Lu YS, Cheng CH, Wu MJ, Lian JD: Long-term outcome of adult patients with minimal urinary abnormalities and normal renal function. Clin Nephrol 1999;52:5-9.
5. Fofi C, Pecci G, Galliani M, Comunian M, Muda A, Pierucci A, Cinotti G: IgA nephropathy: multivariate statistical analysis aimed at predicting outcome. J Nephrol 2001;14:280-285.
6. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
7. Churg J, Bernstein J, Glassock RJ: WHO Monograph. Renal Disease: Classification and Atlas of Glomerular Diseases, ed 2. Tokyo, Igaku-Shoin, 1995.
8. D'Amico G: Natural history of idiopathic IgA nephropathy? Role of clinical and histologic prognostic factors. Am J Kidney Dis 2000;36:227-237.
9. Haas M: Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997;29:829-842.
10. Myllymaki J, Saha H, Mustonen J, et al: IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis 2003;41:343-350.
11. Harmankaya O, Ozturk Y, Basturk T, et al: Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria. Int Urol Nephrol 2002;33:167-171.
12. Kanno Y, Okada H, Saruta T, Suzuki H: Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up. Clin Nephrol 2000;54:360-365.
13. Sezto C, Lai F, To K, Wong T, Chow K, Choi P, Lui S, Li P: The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001;110:434-437.
14. McGregor DO, Lynn KL, Bailey RR: Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria. Clin Nephrol 1998;49:345-348.
15. Rauta V, Finne P, Fagerudd J, Rosenlof K, Tornroth T, Riska C: Factors associated with progression of IgA nephropathy are related to renal function - a model for estimating risk progression in mild disease. Clin Nephrol 2002;58:85-94.
16. Hall CL, Bradley R, Kerr A: Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria. Clin Nephrol 2004;62:267-272.
17. Chow KM, Kwan BC, Li PK: Asymptomatic isolated microscopic haematuria: long-term follow-up. QJM 2004;97:739-745.
18. Yamagata K, Yamagata Y, Kobayashi M, Koyama A: A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 1996;45:281-288.
19. Hogg RJ, Silva FG, Wyatt RJ: Prognostic indicators in children with IgA nephropathy - report of the South-West Pediatric Nephrology Study Group. Pediatr Nephrol 1994;8:15-20.
20. Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid PS, Sinclair R, McNeil JJ, Atkins RC: The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant 2001;16:1364-1367.
21. Maisonneuve P, Agodoa L, Gellert R, Stewart J, Buccianti G, Lowenfels A, Wolfe R, Jones E, Disney A: Distribution of primary renal diseases leading to end-stage renal failure in the USA, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000;35:157-165.
22. Koyama A, Igarashi M, Kobayashi M: Natural history and risk factors for immunoglobulin A nephropathy. Am J Kidney Dis 1997;29:526-532.
23. Nieuwhof C, Doorenbos C, Grave W, Heer F, Leeuw P, Zeppenfeldt E, Peter JC: A prospective study of the natural history of idiopathic non-proteinuric hematuria. Kidney Int 1996;49:222-225.
24. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena F, Remuzzi G: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999;354:359-364.
25. Brenner BM, Cooper ME, de Zeeuw D: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869.
26. Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G: Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 2000;35:1155-1165.
27. Maschio G, Cagnoli L, Claroni F: ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicenter, randomized, placebo-controlled study. Nephrol Dial Transplant 1994;9:265-269.
28. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C: Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet 1999;353:883-887.
29. D'Amico G: Tubulointerstitium as predictor of progression of glomerular diseases. Nephron 1999;83:289-295.
30. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
31. Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier J, Berland Y: Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 2002;35:13-20.
32. Shiiki H, Nishino T, Uyama H: Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis. Clin Nephrol 1996;46:362-368.